Library · Procedure
Renal biopsy
Make it clearer
A renal biopsy means taking a small piece of the kidney to look at it under a microscope. It is not done out of curiosity: it is a way to see what is going on when there is kidney disease.
There are two ways to take it, and they answer different questions. A targeted biopsy goes after a target: a mass-forming lesion, that is, a lump, and it helps figure out what that lump is. A nontargeted biopsy is not chasing any lump; it samples the renal cortex, the outer layer of the kidney, to diagnose systemic diseases that affect the kidney, meaning diseases of the whole body that show up there. One goes to the lump already seen; the other examines the wall of the house.
The preferred route is percutaneous and image guided: entry is through the skin, following the path on a screen. It is preferred because it is minimally invasive and because it has relatively few complications. And the tissue core has higher sensitivity than fine-needle aspiration, meaning it misses fewer cases, and higher specificity, meaning it points to the disease with fewer false alarms.
In brief
A renal biopsy takes tissue from the kidney to examine under a microscope and assess kidney disease.
There are two types: targeted, which helps diagnose a mass-forming lesion, and nontargeted, which samples renal cortex for systemic diseases.
One goes to the lump already seen; the other examines the wall of the house.
The image-guided percutaneous approach is preferred because it is minimally invasive with relatively few complications, and the core has higher sensitivity and specificity than fine-needle aspiration.
Sources (1)
- National Center for Biotechnology Information, StatPearls PublishingRenal Biopsy, StatPearlsPublished
This page explains the topic in general terms; it does not tell anyone what treatment to follow.
Updated